A tumor-associated splice-isoform of


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
14 07 2020
Historique:
pubmed: 1 7 2020
medline: 22 9 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

Master splicing regulator MBNL1 shapes large transcriptomic changes that drive cellular differentiation during development. Here we demonstrate that MBNL1 is a suppressor of tumor dedifferentiation. We surveyed

Identifiants

pubmed: 32601196
pii: 2002499117
doi: 10.1073/pnas.2002499117
pmc: PMC7368273
doi:

Substances chimiques

MBNL1 protein, human 0
Protein Isoforms 0
RNA-Binding Proteins 0
MAP Kinase Kinase 4 EC 2.7.12.2
MAP Kinase Kinase 7 EC 2.7.12.2
MAP2K7 protein, human EC 2.7.12.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16391-16400

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Competing interest statement: D.R is an inventor on a patent “Stratification of Cancer Patients by MBNL1 and MAP2K7Δexon2 Expression for Susceptibility to JNK Inhibition” filed in the Singapore patent office, Provisional Application No. 10201910208U. D.M.E is the founder, director, and CEO of Black Diamond Therapeutics and a consultant to Engine Bioscience in areas unrelated to this manuscript.

Références

Cell Stem Cell. 2012 Feb 3;10(2):111-2
pubmed: 22305559
Nucleic Acids Res. 2014;42(17):10873-87
pubmed: 25183524
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Res. 2012 Jan 15;72(2):379-86
pubmed: 22253282
Exp Neurol. 2009 Sep;219(1):146-55
pubmed: 19445931
Genes Dev. 2015 Oct 1;29(19):2054-66
pubmed: 26443849
Oncogene. 2014 Nov 13;33(46):5311-8
pubmed: 24336324
Genes Dev. 2010 Nov 1;24(21):2343-64
pubmed: 21041405
RNA. 2007 Dec;13(12):2238-51
pubmed: 17942744
Nat Genet. 2008 May;40(5):499-507
pubmed: 18443585
Sci Signal. 2018 Apr 17;11(526):
pubmed: 29666306
Genome Biol. 2009;10(3):R30
pubmed: 19296853
J Biol Chem. 2011 Sep 30;286(39):34224-33
pubmed: 21832083
Nucleic Acids Res. 2015 May 26;43(10):5130-44
pubmed: 25908786
Genes Cancer. 2013 Sep;4(9-10):388-96
pubmed: 24349636
Nat Rev Mol Cell Biol. 2017 Jul;18(7):437-451
pubmed: 28488700
Int J Cancer. 2018 Sep 1;143(5):1162-1175
pubmed: 29577277
J Neurosci. 2016 Nov 9;36(45):11418-11426
pubmed: 27911744
Genes Cancer. 2013 Sep;4(9-10):397-400
pubmed: 24349637
Genes Dev. 2016 Feb 15;30(4):386-98
pubmed: 26883358
EMBO Rep. 2014 Mar;15(3):244-53
pubmed: 24531722
Nat Methods. 2010 Dec;7(12):1009-15
pubmed: 21057496
Cell. 2011 Sep 30;147(1):132-46
pubmed: 21924763
Acta Pharmacol Sin. 2013 Jun;34(6):732-40
pubmed: 23685952
Nature. 2013 Jun 13;498(7453):241-5
pubmed: 23739326
Cell Rep. 2014 May 8;7(3):747-61
pubmed: 24767994
PLoS Comput Biol. 2009 Nov;5(11):e1000553
pubmed: 19893621
BMC Gastroenterol. 2011 Jun 14;11:71
pubmed: 21669008
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Int J Oncol. 2019 Mar;54(3):955-965
pubmed: 30664186
Int J Biol Sci. 2015 Nov 01;11(12):1363-75
pubmed: 26681916
Cell. 2019 May 16;177(5):1172-1186.e14
pubmed: 31031009
Cancer Res. 2017 May 15;77(10):2735-2745
pubmed: 28249897
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Biol Chem. 2006 May 12;281(19):13169-79
pubmed: 16533805
Mol Cancer Ther. 2017 Sep;16(9):1967-1978
pubmed: 28611109
Nature. 2011 Jan 13;469(7329):231-5
pubmed: 21196933
Biochim Biophys Acta. 2013 Feb;1830(2):2280-96
pubmed: 22959078
Life Sci Alliance. 2018 Sep 7;1(5):e201800157
pubmed: 30456384
Mol Cell. 2014 Oct 23;56(2):311-322
pubmed: 25263597
Sci Rep. 2012;2:209
pubmed: 22355723
Oncogene. 2017 May 4;36(18):2599-2608
pubmed: 27941886
Cancer Immunol Res. 2016 May;4(5):390-9
pubmed: 26980599
Genome Res. 2016 Jun;26(6):732-44
pubmed: 27197215
Genes Dev. 2019 Feb 1;33(3-4):166-179
pubmed: 30692202
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
J Biol Chem. 2011 May 6;286(18):16435-46
pubmed: 21454535
Mol Cell. 2013 Dec 12;52(5):720-33
pubmed: 24332178
EMBO Mol Med. 2013 Dec;5(12):1887-900
pubmed: 24293317

Auteurs

Debleena Ray (D)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore; debleena.ray@duke-nus.edu.sg david.epstein@duke-nus.edu.sg.

Yu Chye Yun (YC)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore.

Muhammad Idris (M)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore.

Shanshan Cheng (S)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore.
Centre for Computational Biology, Duke-NUS Medical School, 165897 Singapore, Singapore.

Arnoud Boot (A)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore.
Centre for Computational Biology, Duke-NUS Medical School, 165897 Singapore, Singapore.

Tan Bee Huat Iain (TBH)

Division of Medical Oncology, National Cancer Centre, 169610 Singapore, Singapore.

Steven G Rozen (SG)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore.
Centre for Computational Biology, Duke-NUS Medical School, 165897 Singapore, Singapore.

Patrick Tan (P)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore.

David M Epstein (DM)

Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 165897 Singapore, Singapore; debleena.ray@duke-nus.edu.sg david.epstein@duke-nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH